Maravai LifeSciences Holdings, Inc.
MRVI
$3.51
$0.072.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.67% | -304.44% | -147.93% | 75.33% | -1,402.23% |
| Total Depreciation and Amortization | 10.00% | 5.77% | 8.41% | 11.91% | 7.20% |
| Total Amortization of Deferred Charges | -47.08% | -47.45% | -37.70% | -11.44% | 2.17% |
| Total Other Non-Cash Items | -111.01% | 115.32% | -26.97% | -93.51% | 5,337.23% |
| Change in Net Operating Assets | 109.44% | -81.49% | 151.59% | -520.93% | -73.18% |
| Cash from Operations | -215.33% | -158.88% | -10.90% | -287.91% | -7.27% |
| Capital Expenditure | 65.94% | 69.92% | 7.59% | 65.18% | 45.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -100.00% | -48.35% | -76.44% | -219.87% |
| Cash from Investing | 67.34% | 47.65% | -444.98% | 61.78% | 42.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.63% | -2.59% | -2.52% | -15,245.74% | -2.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -230.22% | -71.51% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -389.61% | -100.00% | -42.18% | -360.31% | 20.10% |
| Cash from Financing | -1,119.65% | -772.81% | -775.00% | -50,352.98% | 3.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -628.14% | -231.93% | -181.41% | -5,408.46% | 973.20% |